| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $696.2M | $657.3M | $691.3M |
| YoY Revenue Growth % | +5.9% | -4.9% | — |
| Gross Profit | $161.0M | $171.9M | — |
| Gross Margin % | 23.1% | 26.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$28.4M | -$3.8M | $22.5M |
| Operating Margin % | -4.1% | -0.6% | 3.3% |
| Net Income (GAAP) | -$97.0M | -$11.1M | $12.4M |
| EBITDA (Normalized) | $1.3M | $25.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $29.7M | $25.7M | $20.5M |
| Capital Expenditures (CapEx) | $37.2M | $37.1M | — |
| Free Cash Flow (FCF) | -$7.5M | -$11.4M | $20.5M |
| FCF Margin % | -1.1% | -1.7% | 3.0% |
| Return on Invested Capital (ROIC %) | -3.6% | -0.4% | — |
| Cash & Short-Term Equivalents | $196.3M | $182.6M | — |
| Total Debt (Short + Long Term) | $2.1M | $20.8M | — |
| Total Stockholders' Equity | $818.8M | $902.6M | — |